AgeX Therapeutics Inc (DELISTED) (AGE:DL)
11.10
-1.50
(-11.90%)
USD |
NYAM |
Mar 26, 16:00
12.18
+1.08
(+9.73%)
After-Hours: 20:00
AgeX Therapeutics Cash from Operations (Quarterly): -1.864M for Sept. 30, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -1.864M |
| June 30, 2023 | -2.019M |
| March 31, 2023 | -1.865M |
| December 31, 2022 | -1.321M |
| September 30, 2022 | -1.236M |
| June 30, 2022 | -1.746M |
| March 31, 2022 | -1.636M |
| December 31, 2021 | -1.647M |
| September 30, 2021 | -1.884M |
| June 30, 2021 | -1.694M |
| March 31, 2021 | -2.63M |
| December 31, 2020 | -1.62M |
| Date | Value |
|---|---|
| September 30, 2020 | -1.889M |
| June 30, 2020 | -2.244M |
| March 31, 2020 | -2.064M |
| December 31, 2019 | -2.411M |
| September 30, 2019 | -2.372M |
| June 30, 2019 | -2.759M |
| March 31, 2019 | -2.618M |
| December 31, 2018 | -2.046M |
| September 30, 2018 | -1.783M |
| June 30, 2018 | -2.161M |
| March 31, 2018 | -2.005M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-2.759M
Minimum
Jun 2019
-1.236M
Maximum
Sep 2022
-1.939M
Average
-1.874M
Median
Cash from Operations (Quarterly) Benchmarks
| Homology Medicines Inc (DELISTED) | -21.58M |
| NovaBay Pharmaceuticals Inc | -1.572M |
| Palatin Technologies Inc | -8.607M |
| iBio Inc | -3.654M |
| Theriva Biologics Inc | -4.881M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | 2.00M |
| Free Cash Flow | -7.069M |
| Free Cash Flow Per Share (Quarterly) | -1.727 |
| Free Cash Flow to Equity (Quarterly) | 28.93M |
| Free Cash Flow Yield | -59.02% |